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Members of the cytochrome P450 3A subfamily catalyze the metabolism of endogenous substrates, environmental
carcinogens, and clinically important exogenous compounds, such as prescription drugs and therapeutic agents. In
particular, the CYP3A4 and CYP3A5 genes play an especially important role in pharmacogenetics, since they
metabolize 150% of the drugs on the market. However, known genetic variants at these two loci are not sufﬁcient
to account for the observed phenotypic variability in drug response. We used a comparative genomics approach
to identify conserved coding and noncoding regions at these genes and resequenced them in three ethnically diverse
human populations. We show that remarkable interpopulation differences exist with regard to frequency spectrum
and haplotype structure. The non-African samples are characterized by a marked excess of rare variants and the
presence of a homogeneous group of long-range haplotypes at high frequency. The CYP3A5*1/*3 polymorphism,
which is likely to inﬂuence salt and water retention and risk for salt-sensitive hypertension, was genotyped in 11,000
individuals from 52 worldwide population samples. The results reveal an unusual geographic pattern whereby the
CYP3A5*3 frequency shows extreme variation across human populations and is signiﬁcantly correlatedwith distance
from the equator. Furthermore, we show that an unlinked variant, AGT M235T, previously implicated in hyper-
tension and pre-eclampsia, exhibits a similar geographic distribution and is signiﬁcantly correlated in frequency with
CYP3A5*1/*3. Taken together, these results suggest that variants that inﬂuence salt homeostasis were the targets
of a shared selective pressure that resulted from an environmental variable correlated with latitude.
Introduction
Cytochrome P450 (CYP) genes are abundant in animal,
plant, and bacterial genomes and have evolved to me-
tabolize a variety of diverse compounds. Among the most
abundant and clinically important of human CYP en-
zymes are members of the CYP3A subfamily, which cat-
alyze the metabolism of endogenous substrates, ranging
from bile acids to steroids such as estrogen and testos-
terone, as well as environmental carcinogens such as
pesticides. CYP3A enzymes also play important roles in
the bioavailability and clearance of a wide range of ex-
ogenous compounds in the form of prescription drugs
and therapeutic agents (Lamba et al. 2002a).
Interindividual variability in clearance of CYP3A sub-
strates can result from the effects of inducers, inhibitors,
or genetic or dietary factors that potentially lead to dif-
ferences in drug toxicity and response. It is estimated that
genetic factors are responsible for 70%–90% of inter-
individual variability in constitutive expression (Ozde-
mir et al. 2000), but few genetic determinants that un-
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derlie this variation are known. Genetic variants that
change the amino acid sequence tend to be rare and,
although there are a few common noncoding SNPs that
affect gene expression and/or activity, the known vari-
ants fail to account completely for the observed pheno-
typic variation (Lamba et al. 2002b).
Members of the CYP3A subfamily are located on
chromosome 7q22 and span ∼220 kb. The four genes
include CYP3A4 (MIM 124010), which is the domi-
nant adult enzyme and is expressed primarily in liver
and small intestine; CYP3A5 (MIM 605325), which
is expressed in liver, kidney, intestine, and prostate
gland; CYP3A7 (MIM 605340), which is expressed
fetally; and CYP3A43 (MIM 606534), which is ex-
pressed at low levels in a number of tissues. In many
populations, total adult CYP3A protein content con-
sists largely of CYP3A4; however, extreme interpopu-
lation variability exists with regard to CYP3A5 ex-
pression. This variation is largely due to a single-base
substitution in intron 3 of CYP3A5, which results in
an incorrectly spliced mRNA and a nonfunctional
protein (Kuehl et al. 2001). This allele, known as
“CYP3A5*3,” was reported to have a frequency of
∼27%–50% among African Americans, 85%–95%
among whites (Hustert et al. 2001; Kuehl et al. 2001),
and 60%–73% among Asians (Hustert et al. 2001).
Therefore, the proportion of CYP3A5 in the total liver
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and intestinal CYP3A pool is lower in carriers of the
CYP3A5*3 allele, which creates the potential for dif-
ferential drug response. In addition, it has been sug-
gested that the expressor allele may be associated with
increased systolic blood pressure andmean arterial pres-
sure in African Americans (Givens et al. 2003). The
proposed mechanism involves the conversion of cortisol
to 6b-hydroxycortisol by CYP3A5 in the kidney, which
leads to higher reabsorption of sodium and water re-
tention as well as the clinical phenotype of salt-sensitive
hypertension. It was proposed that the expressor allele
confers a selective advantage in equatorial populations
that may experience water shortages (Kuehl et al. 2001).
Here, we used a comparative genomics approach to
pinpoint regions of potential interest for our resequencing
study, with the idea that highly conserved sequences
between distantly related species may harbor regulatory
elements that affect gene expression.We combined com-
parative genomics with computational predictions of
clusters of liver-enriched transcription-factor-binding
sites. These sequence elements, together with the coding
regions and the known regulatory elements, were sur-
veyed in ethnically diverse samples to uncover addi-
tional functional variation, which can be further ex-
amined for its possible role in interindividual variability
in drug response. In addition, we investigated the role
of natural selection in shaping patterns of variation at
the CYP3A locus. Our results show a striking haplotype
structure, large allele frequency differences between Af-
rican Americans and non-African populations, and a
signiﬁcant correlation betweenCYP3A5*1/*3 allele fre-
quency and distance from the equator. We also observed
a signiﬁcant correlation, in the same population sam-
ples, between the frequency of an additional unlinked
variant that inﬂuences salt sensitivity (AGT M235T
[MIM 106150]) and distance from the equator. These
ﬁndings argue for a shared selective pressure on salt-
sensitivity variants, with the intensity of selection vary-
ing in correlation with latitude.
Material and Methods
Library Screening and BAC-Clone Sequencing
Universal oligonucleotide probes (overgos) were de-
signed on the basis of an alignment of human, mouse,
and rat CYP3A coding sequences (Thomas et al. 2002)
and were used to screen BAC libraries for the mouse
(RPCI-23), rat (RPCI-32), dog (RPCI-81), and olive ba-
boon (RPCI-41). The positive clones were sequenced by
the random shotgun approach (Roe 2004).
Comparative Analysis and Resequencing-Study Design
Regions included in the resequencing study were iden-
tiﬁed by alignment of all nonhuman Cyp3A genes to the
human CYP3A4 or CYP3A5 sequences (GenBank acces-
sion numbers AC069294 and AC005020, respectively).
Mouse and rat sequence information included additional
clones from public databases. Because the ancestral re-
lationships between these genes cannot be determined
unambiguously, we included multiple genes from each
of the nonhuman species that are closely related to
CYP3A4 and CYP3A5. Human sequences were ana-
lyzed with Cluster-Buster (Frith et al. 2003), to predict
clusters of binding sites for the liver-enriched transcrip-
tion factors HNF1a, HNF4, PXR/CAR, OCT-1, PPAR/
RXR, CEBP, HNF3b, and HNF4/COUP-TF. Three
regions that contained clusters predicted with high prob-
ability and conserved across all ﬁve specieswere included
in the resequencing study.
DNA Samples
Human population samples consisted of 24 Europeans,
23 African Americans, and 23 Han from Los Angeles; all
individuals are unrelated and are subsets of three Human
Variation panels in the Coriell Cell Repositories (Cauca-
sian, African American, and Han People of Los Angeles).
Sample information can be obtained from the PharmGKB
Web site (accession numbers PS203894 and PS203895).
The orthologous regions were sequenced in a western
chimpanzee (Pan troglodytes verus). SNP typing was per-
formed on the entire Human Genome Diversity Panel–
Centre d’Etude du Polymorphisme Humain (HGDP-
CEPH). This study was approved by the institutional
review board of the University of Chicago.
PCR Ampliﬁcation and Sequencing
PCR and sequencing primers (available from the
PharmGKB Web site) were designed on the basis of
GenBank sequences AC069294 and AC005020 for
CYP3A4 and CYP3A5, respectively; all nucleotide po-
sitions in this article are numbered according to those
sequences. PCR and sequencing were performed as de-
scribed elsewhere (Wall et al. 2003). The same primers
were used to amplify and sequence the human and the
chimpanzee samples. In addition to PharmGKB, sample
information, primer sequences, polymorphism data, and
outgroup sequences are available on the Di Rienzo lab
Web site.
Data Analysis
Population genetics summary statistics were calculated
using SLIDER and MAXDIP. FD′F and were calcu-2r
lated from diploid data, according to the maximum-
likelihood method (Hill 1974). Haplotypes were inferred
in each population sample separately, by use of PHASE2
(Stephens et al. 2001). Singleton sites were omitted from
the haplotype inference. Fay and Wu’s H test (Fay and
Wu 2000) was performed using DnaSP version 4.0 (Ro-
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e pa TDb vW
c vW:div
d rH01
e pa TDb vW
c rH01
e
CYP3A4 16,822 .46 .58 (49) .55 6.7% (6) .52 .14 1.76 (3) .31 3.7% (11) .37 .1 .75 .14 .62
CYP3A5 14,573 .26 1.13 (12) .39 5.5% (2.8) .36 .06 2.11 (1) .19 2.9% (2.8) .00 .06 1.21 .11 .00
a Nucleotide diversity per bp ( ).3#10
b Tajima’s D (Tajima 1989). Numbers in parenthesis indicate the percentile rank of the TD value relative to the distribution of TD values
in the SeattleSNP genes.
c Watterson’s estimator of the population-mutation-rate parameter v ( ) per bp ( ) (Watterson 1975).3p 4Nm #10
d Ratio of vW to the amount of sequence divergence (div) between human and chimpanzee. Numbers in parenthesis indicate the percentile
rank of the vW:div value relative to the distribution of vW:div values in the SeattleSNP genes.
e Composite likelihood estimator of the population recombination-rate parameter ( ) per bp ( ) based on a gene-conversion–to–34Nr #10
crossover-rate ratio of 2 and mean-conversion-tract length of 500 bp (Frisse et al. 2001; Hudson 2001).
zas and Rozas 1995). Coalescent simulations for the H
and haplotype tests were performed assuming values of
estimated from the data for each population sample.4Nr
SNP Genotyping
For the CYP3A5*1/*3 polymorphism, we modiﬁed
a mismatch PCR-based RFLP protocol by ﬁrst perform-
ing PCR with primers speciﬁc to CYP3A5 (Cyp5Ex4F-
Cyp5Ex4R) (sequences available from PharmGKB) fol-
lowed by a nested PCR (Fukuen et al. 2002). The nested
PCR product was digested with DdeI and was visualized
on 3% agarose gel electrophoresis.
For the AGT M235T polymorphism, we also used a
mismatch PCR-based RFLP assay. Genomic DNA was
subjected to a ﬁrst round of ampliﬁcation with primers
5′-CAACTTCTTGGGCTTCCGTA-3′ and 5′-TGCACA-
TAGTAGGGCAGCAG-3′, under the following condi-
tions: initial denaturation at 94C for 2 min, followed
by 34 cycles of 94C for 30 s, 64.6C for 30 s, and 72C
for 1.5 min, and a ﬁnal extension of 72C for 1 min.
Of this product, 1 ml was diluted 50-fold and was used
as template in a nested PCR reaction, by use of primer
sequences published elsewhere (Russ et al. 1993) and an
annealing temperature of 67C; 4 ml of product was di-
gested overnight with 5 units of Tth111 I in a 50-ml
reaction volume, and the digested products were visu-
alized on a 3% agarose gel.
Results
Sequence Variation and the Frequency Spectrum
The extent of sequence identity across species at the
CYP3A4 and CYP3A5 genes is shown in ﬁgure A1 (on-
line only). Computational predictions of clusters of liver-
enriched transcription-binding sites identiﬁed ﬁve regions
with high probability. Two of them are not conserved and
were not included in our survey. The remaining three,
two of which fall in intronic sequences and one of which
is 10.5 kb upstream of CYP3A4, are conserved across
species and were included in our survey. The same seg-
ments were sequenced in one chimpanzee.
The surveyed sequence spans ∼150 kb and contains
1.6 kb of coding sequence and 15.2 kb of conserved non-
coding sequence (CNS) for CYP3A4 and 1.6 kb of cod-
ing sequence and 13.2 kb of CNS for CYP3A5. We iden-
tiﬁed a total of 92 polymorphic sites (including one
multiallelic and six biallelic indels), of which 5 were
nonsynonymous, 4 were synonymous, and 83 were non-
coding. Twelve noncoding SNPs occurred at highly con-
served nucleotide positions—that is, positions where the
ancestral allele (inferred by comparison with the chim-
panzee sequence) was identical to the base found in the
remaining four species. Sequence divergence betweenhu-
man and chimpanzee is relatively low (0.86% and 0.66%
for CYP3A4 and CYP3A5, respectively) compared with
the genomewide average of 1.24% (Ebersberger et al.
2002).
Summary statistics of the polymorphism data are
shown in table 1, and a visual representation of the se-
quence data, in the form of inferred haplotypes, is shown
in ﬁgure 1. Polymorphism levels, as summarized by nu-
cleotide diversity (p) and Watterson’s estimator of the
population mutation rate parameter v (vW), are low for
both genes. Linkage-disequilibrium (LD) levels summa-
rized by rH01, an estimator of the population-recombi-
nation rate parameter ( ) (Frisse et al. 2001; Hudson4Nr
2001), are also on the low side, especially for CYP3A5
in the non-African samples. The Tajima’s D statistic,
which summarizes information about the spectrum of
allele frequencies (Tajima 1989), is expected to be near
zero, under the neutral equilibrium model. A positive
value indicates an excess of intermediate frequency vari-
ants consistent with the effects of balancing selection or
population subdivision, whereas a negative value indi-
cates a skew toward rare variants and suggests the action
of directional selection or population growth. The nega-
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Figure 1 Inferred haplotypes at CYP3A4 and CYP3A5. Neither
singleton sites nor multiallelic indels were included. The chimpanzee
sequence was used to infer the ancestral allele at each site. The numbers
on the right indicate the number of haplotypes in each population.
The asterisk (*) indicates the position of CYP3A5*1/*3. Numbers
below the gene names indicate the position of each polymorphic site
relative to the reference sequence for each gene (GenBank accession
numbers AC069294 and AC005020 for CYP3A4 and CYP3A5,
respectively).
tive Tajima’s D values at the CYP3A4 and CYP3A5
genes indicate an excess of rare variants; this, together
with the low polymorphism levels, raises the possibility
of a selective sweep.
An excess of high frequency derived alleles may be
expected soon after a selective sweep is completed or at
some stage during an ongoing sweep and can be assessed
by means of the H test (Fay and Wu 2000). The results
of the H test were signiﬁcant for CYP3A4 in the Eu-
ropean and Asian samples ( and , re-Pp .006 Pp .003
spectively). The results forCYP3A5were not statistically
signiﬁcant for any population sample; however, the power
of the test may be low because of the small number of
polymorphic sites at this locus. The inferred haplotypes
in ﬁgure 1 show that the high-frequency-derived alleles
tend to be in strong LD (see also ﬁg. A2 [online only]).
Two haplotypes, which differ from each other by a single
site, account for 60% and 65% of the European and Han
haplotypes, respectively. These results suggest that the
pattern detected by theH test in the non-African samples
is largely due to the increase in frequency of one hap-
lotype class that contains several derived alleles and that
spans ∼150 kb. We used the haplotype test (Hudson et
al. 1994) to ask if the haplotype structure is indeed in-
consistent with the neutral-equilibrium model. We ran
coalescent simulations to generate 1,000 samples that
contained the same number of polymorphic sites ob-
served in the total surveyed segment (that contained both
CYP3A4 and CYP3A5) in the European and Han sam-
ples, and we calculated the proportion of simulated sam-
ples that contained a subset that accounted for 60% and
65% of the haplotypes, respectively, and contained one
or no polymorphic site (Hudson et al. 1994). This pro-
portion is 0.2% and 2% in Europeans and Han, re-
spectively, and it suggests that the haplotype structure
is indeed unusual.
To assess whether the low polymorphism levels and
the skew toward rare variants is unusual, we compared
our results with the data (referred to as “SeattleSNPs”)
of the University of Washington–Fred Hutchinson Can-
cer Research Center Variation Discovery Resource that
focuses on genes involved in inﬂammation. Statistical
tests of neutrality, including the H and the haplotype
tests, assume a population at equilibrium. However, hu-
man populations do not ﬁt the equilibrium expectations.
Comparing the CYP3A4 and CYP3A5 genes with an em-
pirical distribution, such as that of the SeattleSNP genes,
circumvents this problem. This comparison was facili-
tated by the fact that the European and African Ameri-
can samples used in our study are the same as those used
in the SeattleSNP project; no Asian data is available in
the SeattleSNP data set. To take into account the strong
evolutionary constraints in the surveyed segments, we
normalized the polymorphism levels according to the
amount of interspecies sequence divergence by taking
the ratio of vW and sequence divergence between human
and chimpanzee; the value obtained for theCYP3A4 and
CYP3A5 genes was compared with the distribution of
the same quantity in the 159 SeattleSNP genes (table 1).
The same comparison was made for the Tajima’s D val-
ues. A summary of the distribution of the SeattleSNP
polymorphism data is given in table 2. Although on the
low end of the distribution for the SeattleSNP genes, the
polymorphism levels normalized for interspecies diver-
gence observed in CYP3A4 are not unusual; a more
marked reduction is seen at CYP3A5, in which the ratio
of vW and interspecies divergence is in the 2.8th per-
centile of the SeattleSNP distribution for both African
Americans and Europeans. Tajima’s D values in the Eu-
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Range Mean Range Mean
African Americans 24 1.70 to 1.53 .54 .045 to .336 .116
Europeans 23 2.80 to 2.46 .22 .022 to .206 .071
a Number of individuals in the sample.
b Ratio of vW to the amount of sequence divergence (div) between human
and chimpanzee.
ropean sample were unusually low for both CYP3A4
and CYP3A5 compared with the SeattleSNP data set,
whereas the values for the African American sample
were well within the observed range. Thus, the com-
parison of our data with an empirical distribution is in
qualitative agreement with the results of statistical tests
of neutrality based on the equilibrium model in sug-
gesting a role for directional selection in the CYP3A
locus.
Geographic Distribution of CYP3A5*3 Allele
Frequency
One of the variants that deﬁnes the haplotype class
found at near-ﬁxation frequency in non-Africans is the
nonexpressor allele at CYP3A5 (CYP3A5*3). The hap-
lotype structure and marked skew toward rare variants
in the non-African samples coupled with the likely phe-
notypic and ﬁtness effects associated with this allele sug-
gest that it was quickly driven to high frequency by posi-
tive natural selection outside Africa. We typed this poly-
morphism in 1,064 individuals from 52 different world
populations in the HGDP-CEPH panel (table A1 [online
only]). The frequency of the CYP3A5*3 allele is lowest
in sub-Saharan Africa (0.07 in Namibia and the Congo;
0.06 in Nigeria) and highest in European and East Asian
populations (0.96 in France; 0.95 in Italy and regions
of China). Interestingly, the frequency of the CYP3A5*3
allele increases with distance from the equator (ﬁg. 2A)
(Spearman rank correlation ; ).scorep 0.612 P ! .0001
A signiﬁcant rank correlation was also observed for 18
East Asian populations that span 51 of latitude (rank
correlation ; ), but not for thescorep 0.649 Pp .0077
7 European populations that span only 21 of latitude.
Because nearby populations are likely to exchange
genes more often than distant populations, it is possible
that a correlation between allele frequency and latitude
is often observed for this set of populations simply as a
result of their geographic structure and history of mi-
gration. Ideally, a comparison with a large data set of
biallelic markers typed in the same population samples
could address this issue. In the absence of biallelic marker
data, we compared our ﬁndings with the results of a
genomewide survey of microsatellite variation at 404
loci typed in exactly the same individuals. These loci
were shown to exhibit levels of interpopulation differ-
entiation comparable to those of biallelic markers (Ro-
senberg et al. 2002). We selected a total of 276 micro-
satellite alleles, 1 per locus, with global allele fre-
quencies within 5% of that of CYP3A5*3, and we com-
puted the rank correlation score between each micro-
satellite allele frequency and the distance of each popu-
lation from the equator. Only two microsatellite alleles
had a more extreme correlation score than that observed
for CYP3A5*3. We repeated the analysis by matching
the allele frequencies in the pool of sub-Saharan African
populations instead of matching the global-allele fre-
quencies: we selected 377 alleles, and only 1 of them had
a more extreme correlation score than did CYP3A5*3.
This indicates that the geographic distribution of the
CYP3A5*3 allele frequency is indeed unusual and sug-
gests that it may be due to a selective advantage, con-
ferred by this allele, that increases with increasing
latitudes.
Because of the high degree of LD in this region (ﬁg.
A2 [online only]), several SNPs in our resequencing
survey share the large allele frequency differences be-
tween African Americans and non-Africans observed for
CYP3A5*3. FST, a statistic that summarizes allele fre-
quency differentiation between samples, was estimated
per site between each of the two non-African samples
and the African American sample. Whereas average FST
values in worldwide human populations are ∼0.123
(Akey et al. 2002), seven and two SNPs in CYP3A4 and
CYP3A5, respectively, had an FST 10.5 between African
Americans and the non-Africans, reaching a maximum
of 0.66. It was previously estimated that only 1.9% of
SNPs had a difference in allele frequency between Af-
rican Americans and Europeans 0.5 (Akey et al. 2002;
Rosenberg et al. 2003). In our data set, 8 (21%) of 38
SNPs with minor-allele frequency 15% showed such a
large difference in allele frequency. In 5 (11%) of 44
SNPs, the allele frequencies differed by 10.5 between
African Americans and Han. This further corroborates
the notion that the pattern of geographic differentiation
at this locus is not simply the result of human population
history.
Figure 2 Geographic distribution of the CYP3A5*3 and AGT Met235 allele frequencies. A, Plot of CYP3A5*3 and AGT Met235 allele
frequencies and distance from the equator (measured in degrees of latitude). B, Plot of CYP3A5*3 versus AGT Met235 allele frequencies, by
subpopulation.
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Geographic Distribution of AGT Met235 Allele
Frequency
Variation in the angiotensinogen gene (AGT) was
shown to inﬂuence risk for human hypertension (Luft
2001) and pregnancy complications (Ward et al. 1993).
A promoter A-6G variant exists in strong LD with the
M235T variant; the combination of the two is reported
to be associated with hypertension (Wu et al. 2004). The
CYP3A5*1/*3 polymorphism appears to have similar
phenotypic effects as these AGT variants. If the salt-
sensitivity phenotypes associated with the CYP3A5 and
AGT variants evolved under the same selective pressures,
one might expect a similar geographic distribution in
these two unlinked genes. To test this hypothesis, we
genotyped the AGT M235T variant in our same popula-
tion samples (i.e., the HGDP-CEPH panel) (table A1
[online only]). As with CYP3A5*3, the frequency of the
derived allele, M235 at AGT, increases with distance
from the equator (ﬁg. 2A) (rank correlation score 0.712;
). A signiﬁcant rank correlation was also ob-P ! .0001
served for 18 East Asian populations (rank correlation
score 0.511; ) but not for the 7 EuropeanPp .0352
populations. When compared with 259 microsatellite
alleles typed in the same population samples and that
have global-allele frequency within 5% of that of AGT
M235, no microsatellite allele had a more extreme cor-
relation score than that observed for the M235 allele.
Matching the allele frequencies in the pool of sub-Sa-
haran African samples did not change the results; that
is, none of 399 alleles with frequencies within the speci-
ﬁed range had a more extreme correlation score than
did CYP3A5*3. As shown in ﬁg. 2B, the frequencies of
the two derived alleles, CYP3A5*3 and AGT M235, are
also signiﬁcantly correlated with each other (rank cor-
relation score 0.680; ).P ! .0001
Discussion
Our comparative genomics-based survey of sequence
variation in three human populations identiﬁed a large
number of variants in noncoding regions that are con-
served across distantly related mammalian species. In
addition, it revealed a striking pattern of haplotype
structure and an excess of rare variants in the non-Af-
rican samples, as well as large differences in allele fre-
quencies between samples of African and non-African
descent. These results suggest that a relatively homo-
geneous class of haplotypes that span 150 kbwere driven
to near-ﬁxation frequency by natural selection in the
non-African populations. The observation of a signiﬁ-
cant rank correlation between the frequency of the
CYP3A5*3 allele that deﬁnes this haplotype class and
distance from the equator further suggests the action of
spatially varying selective pressures. The ﬁnding of a
similar correlation for another variant, AGT M235T,
with similar phenotypic effects supports the idea that
both variants were the targets of a shared selective pres-
sure. Although we cannot rule out the possibility that
other variants in perfect LD with the two SNPs we tested
were the true targets of selection, it seems plausible that
such hypothetical linked variants must similarly affect
salt sensitivity.
Our assessment of the potential signature of natural
selection on the CYP3A genes relies on a combination
of comparisons of theoretical expectations, based on the
neutral equilibrium model, with empirical expectations,
based on a large sequence variation data set (SeattleSNP).
Because human populations have experienced complex
histories, a signiﬁcant departure in tests based on equi-
librium assumptions, such as the H and haplotype tests,
may simply be the result of increased variance across
loci that is due to past bottlenecks and/or population
subdivision. Simulations showed that this is the case
speciﬁcally for the H test (Przeworski 2002); in addi-
tion, human polymorphism data suggest that signiﬁcant
departures in this test may be due to population history
rather than selection (Hamblin et al. 2002). If the true
history of human populations could be inferred accu-
rately, one could perform the same tests under the as-
sumption of the appropriate null neutral model. In the
absence of such information, one can use, for compari-
son, a distribution obtained from a large set of loci
surveyed in the same population samples. If these loci
evolved neutrally, such a distribution would simply re-
ﬂect the stochastic variance associated with the evolu-
tionary process, given the particular history of the popu-
lations examined. This is unlikely to be the case for the
SeattleSNP data, because of the inclusion of genes that
may well have evolved under a variety of selection mod-
els (Akey et al. 2004). Hence, the variance in the dis-
tribution of SeattleSNP genes is likely to be greater than
expected if all the genes were neutral. This makes the
comparison of a candidate target of natural selection
with the SeattleSNP distribution conservative and our
results all the more striking.
A number of characteristic features were observed in
the CYP3A4 and CYP3A5 genes in the non-African sam-
ples: low polymorphism levels (even after normalization
for interspecies divergence), a marked skew toward rare
variants, a large fraction of high-frequency-derived al-
leles, a large subset of inferred haplotypes with low
levels of variation, and above-average differences in al-
lele frequency between populations of African and non-
African descent. The comparison with the SeattleSNP
data for polymorphism levels and the skew toward rare
variants allowed us to determine that the results for the
European population are indeed unusual. An alternative
approach to testing neutrality on the basis of levels of
polymorphism and divergence is the HKA test (Hudson
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et al. 1987), which properly takes the evolutionary vari-
ance into account. However, with regard to human
populations, this test suffers from the same limitations
of other standard tests in that it relies on the theoretical
expectations of the standard neutral model. It is not
obvious how to perform such an empirical comparison
for the aspects of the data used in the H and the hap-
lotype tests; thus, the interpretation of their results is
not straightforward. A further caveat for the haplotype
test is that we used inferred haplotypes without taking
into account the uncertainty in the phase inference,
whereas the test assumes that the haplotype phase is
known. This may lead to an underestimate of the P
value and would not be conservative.
Because of the likely contribution of European genes
(discussed below) and the large interethnic differences
at this locus, the interpretation of the African American
data is not straightforward. Polymorphism levels nor-
malized by interspecies divergence tend to be low in
African Americans, even though a number of polymor-
phic sites may have been introduced through admixture
with European genes. Likewise, the occurrence of vari-
ants at intermediate frequencies in African Americans,
which are nearly ﬁxed in Europeans, suggests that the
frequency spectrum in the native African portion of the
African American gene pool may be more strongly
skewed toward rare variants. Thus, the possibility that
natural selection acted on this locus in Africa cannot be
excluded on the basis of our data. Resequencing surveys
of native African populations will be necessary to ad-
dress this issue.
Despite these caveats, the functional role of the
CYP3A5*1/*3 polymorphism, its likely ﬁtness conse-
quences, and its geographic distribution independently
argue for the action of natural selection on this locus.
CYP3A enzymes convert circulating cortisol to 6-b-hy-
droxycortisol, which plays a role in sodium transport
in the kidney and is hypothesized to result in defective
renal sodium excretion (Ghosh et al. 1995). More spe-
ciﬁcally, the conversion of cortisol to 6-b-hydroxycor-
tisol by CYP3A5 in the kidney, which results in greater
sodium retention, has been proposed to contribute to
salt-sensitive hypertension in humans (Schuetz et al.
1992; Givens et al. 2003). Accordingly, 6-b-hydroxy-
cortisol levels were found to be markedly higher in the
spontaneously hypertensive rat (SHR) than the normo-
tensive control (Schenkman et al. 1989). In addition, a
selective CYP3A inhibitor (TAO) decreases in vivo 6-b-
hydroxycortisol and blood pressure in the SHR (Wat-
lington et al. 1992). Together, the correlation between
renal CYP3A activity and blood pressure in the SHR is
consistent with the idea that increased 6-b-hydroxy-
cortisol production by CYP3A enzymes may play a role
in hypertension.
Phenotypic variability in human hypertension sus-
ceptibility could be due to genetic variation in genes
that underlie salt regulation. The “sodium retention hy-
pothesis” (Gleibermann 1973; Nakajima et al. 2004)
proposes that ancient human populations living in hot,
humid areas with low sodium availability adapted to
their environment by retaining salt, whereas popula-
tions in cooler, temperate climates adapted to conditions
of greater sodium availability. Since an increased preva-
lence of hypertension in African American versus white
populations is well documented and since blood pres-
sure homeostasis is strongly inﬂuenced by sodium regu-
lation and salt sensitivity, population-speciﬁc differences
in susceptibility to hypertension could be explained, in
part, by variation in genes related to salt regulation.
This hypothesis provides a general framework for in-
terpreting the patterns of variation observed at genes
involved in sodium homeostasis. However, in its origi-
nal formulation, an ancestral allele that increases salt
and water retention, such as CYP3A5*1, is expected to
confer a selective advantage that decreases with distance
from the equator but is not necessarily predicted to be-
come deleterious. Interestingly, the near-ﬁxation fre-
quency of the derived CYP3A5*3 allele in many non-
African populations coupled with the unusual patterns
of variation observed in our resequencing survey suggest
that CYP3A5*1 does become deleterious at high lati-
tudes. One possible scenario is that the CYP3A5*1 al-
lele has multiple phenotypic effects with opposite ﬁtness
consequences; the trade off between the advantage and
the disadvantage conferred by this allele changes de-
pendent on an environmental variable correlated with
distance from the equator. An example of a possible
disadvantage associated with CYP3A5*1 is complica-
tions of pregnancy: increased urinary excretion of
6b-hydroxycortisol was observed in women with pre-
eclampsia (Frantz et al. 1960). Thus, whereas the se-
lective advantage due to increased salt and water reten-
tion decreases and possibly disappears completely with
increasing latitude, the selective disadvantage becomes
the main inﬂuence on the overall ﬁtness, which results
in the adaptive rise in frequency of the CYP3A5*3
allele. Alternatively, a different allele in perfect LD with
CYP3A5*3 could have conferred a selective advantage
at higher latitudes over the CYP3A5*1 haplotypes,
which would result in the signature of natural selection
suggested by our data.
Our survey of allele frequency strengthens and ex-
tends previous ﬁndings that the nonexpressor allele
(CYP3A5*3) is highly prevalent outside Africa. The un-
usual geographic distribution of the CYP3A5*3 allele
is striking in two respects. First, the correlation between
allele frequency and distance from the equator is highly
signiﬁcant and cannot be attributed to patterns of hu-
man migration and geographic distance. Second, we ob-
served an enormous range of allele frequencies at this
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site. Such an extreme degree of interpopulation differ-
entiation suggests the impact of population-speciﬁc se-
lective pressures. Interestingly, a similar pattern was ob-
served at AGT, which is involved in risk for hyper-
tension and pregnancy complications (Ward et al. 1993).
At the AGT locus, a promoter A-6G variant exists in
strong LD with the M235T variant; the combination of
the two is reported to be associated with hypertension
(Wu et al. 2004). Lifton et al. (1993) suggested that
increased salt and water retention associated with the
T235 allele may have been advantageous in times of
salt scarcity, with the M235 allele rising to higher fre-
quencies following the move to salt-rich areas outside
Africa. A survey of the AGT gene in worldwide samples
revealed that the A-6 allele is at much higher frequency
in African populations compared with non-African ones
(Nakajima et al. 2004). A comparison of theCYP3A5*3
and AGT G-6 allele frequencies across populations
shared by the two studies reveals a signiﬁcant positive
correlation (Spearman rank correlation ). InPp .0204
addition, we show that the AGT M235 allele frequency
is signiﬁcantly correlated with distance from the equator
and with CYP3A5*3 allele frequency in the HGDP-
CEPH panel. The correlation of allele frequency be-
tween two unlinked SNPs with similar phenotypic ef-
fects is remarkable and suggests a shared selective
pressure with regard to sodium regulation and home-
ostasis. This ﬁnding offers a new perspective on the
search for candidate variants that increase risk for salt-
sensitive hypertension. More generally, one can specu-
late that a correlation between allele frequencies and
environmental variables may identify variants that con-
tribute to common human diseases with different preva-
lence across ethnic groups.
The low number and frequency of coding variants
observed in our sample mirrors the ﬁndings of previous
efforts to explain phenotypic variation in drug metabo-
lism through coding changes at theCYP3A locus (Lamba
et al. 2002b). The most common of these changes was
the CYP3A5*6 allele (np 30597), which occurred at a
frequency of 11% in the African American sample, the
only population in which it was observed. This allele
has been reported almost exclusively in African Ameri-
can populations (10%–13% frequency) and results in
an alternatively spliced and ultimately truncated pro-
tein, which leads to the same effect on function as the
CYP3A5*3 allele. The observation that CYP3A5 ex-
pression is severely compromised by two common al-
leles that exist on different haplotypes is clearly unusual
and is consistent with the idea that the expression of
CYP3A5 may be disadvantageous under some environ-
mental conditions.
The frequency of the CYP3A5*3 allele in African Am-
ericans is 33%, whereas its average frequency in the
native sub-Saharan African populations is 14%. Given
the much higher frequency of this allele in Europeans,
this is consistent with previous results on the contribu-
tion of European genes to the African American gene
pool (Parra et al. 1998). Interestingly, there is a sug-
gestion that CYP3A5*3 haplotypes are more hetero-
geneous in African Americans than in the non-African
populations (ﬁg. 1): most African American haplotypes
closely resemble those observed in the non-African sam-
ples, but a minority lack the derived alleles at ﬁve SNPs
(nps 34914, 40104, 51067, 51927 and 55544) that are
found in most of CYP3A5*3 haplotypes outside Africa.
Two of these SNPs may be functional, since they occur
at positions conserved in all ﬁve species. This raises
the possibility of functional heterogeneity within the
CYP3A5*3 haplotypes across native African popula-
tions and possibly across different African American
populations, depending on the speciﬁc origin of their
sub-Saharan African gene pool. This may have impli-
cations for understanding the contribution of CYP3A
variation to interindividual variation in drug response
in both African and African American populations.
We used sequence comparisons across ﬁve mamma-
lian species and computational predictions to increase
the probability of identiﬁcation of functional variation
that may underlie variability in drug response. The utility
of comparative genomics has been demonstrated else-
where, such as the identiﬁcation of a coordinate regula-
tor of three interleukin genes (Pennacchio and Rubin
2001). We combined this approach with computational
prediction of clusters of transcription-factor-binding
sites. One conserved predicted cluster was recently con-
ﬁrmed as a functional element important for constitu-
tive activation of CYP3A4 (Matsumura et al. 2004).
Four transcription-binding sites—HNF-1, HNF-4, AP-1,
and USF-1—are located in this region, and the inter-
action of these factors with this region was demon-
strated through gel shift assays. The HNF-1 and HNF-
4 binding sites were correctly predicted in our analysis;
AP-1 and USF-1, which are not liver-enriched, were not
included in our search. This ﬁnding validates the utility
of computational predictions and comparative gen-
omics for honing in on putative regulatory elements.
However, it is clear that they should be used in com-
bination with other strategies, as evidenced by the well-
characterized distal xenobiotic-response-enhancermod-
ule (Goodwin et al. 1999), which is neither conserved
nor identiﬁed by prediction algorithms.
It was previously proposed that drug metabolizing
enzyme (DME) genes have diversiﬁed through the co-
evolution of plants and animals. Furthermore, it was
hypothesized that differences in DME allele frequencies
across human populations reﬂected differences in diet
composition over thousands of years (Nebert 1997). The
variety of endogenous and exogenous substrates me-
tabolized by CYP3A4 and CYP3A5 suggests that they
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may be exposed to multiple selective pressures and that
different variants may be the targets of these pressures.
Furthermore, variation in other genes within theCYP3A
gene cluster, namely CYP3A7 and CYP3A43, could add
to the complex evolutionary history of this genomic re-
gion. Additional studies of sequence variation in neigh-
boring genes will allow further testing of the hypotheses
presented in this article.
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